Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
0.8790
+0.0100 (1.15%)
Aug 21, 2025, 4:00 PM - Market closed

Allarity Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
1353478-
Upgrade
Market Cap Growth
179.58%106.50%-40.12%-94.65%--
Upgrade
Enterprise Value
-3-124373-
Upgrade
Last Close Price
0.881.17330.66246787.068714405.71-
Upgrade
PB Ratio
1.060.44-0.912.224.18-
Upgrade
P/TBV Ratio
1.090.44----
Upgrade
Debt / Equity Ratio
0.110.11-0.471.980.060.11
Upgrade
Quick Ratio
2.152.010.080.261.030.27
Upgrade
Current Ratio
2.312.060.140.441.030.31
Upgrade
Return on Equity (ROE)
-150.58%-541.17%--155.34%-123.30%-27.76%
Upgrade
Return on Assets (ROA)
-41.03%-63.52%-81.08%-32.90%-39.98%-16.46%
Upgrade
Return on Capital (ROIC)
-61.58%-187.21%-512.97%-82.82%-70.66%-20.23%
Upgrade
Earnings Yield
-186.02%-472.60%-473.76%-382.75%-33.98%-
Upgrade
FCF Yield
-129.78%-340.25%-507.36%-401.27%-18.98%-
Upgrade
Updated May 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q